BioLife Solutions
BLFS
153 hedge funds and large institutions have $602M invested in BioLife Solutions in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 55 reducing their positions, and 25 closing their positions.
1,019% more call options, than puts
Call options by funds: $358K | Put options by funds: $32K
6.89% more ownership
Funds ownership: 93.3% → 100.19% (+6.9%)
5% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 55
2% less funds holding
Funds holding: 156 → 153 (-3)
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
33% less capital invested
Capital invested by funds: $897M → $602M (-$295M)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$28.5M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$10.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$9.59M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.92M |
| 5 |
RA
Royce & Associates
New York
|
+$3.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCIM
British Columbia Investment Management
Victoria,
British Columbia, Canada
|
-$8.84M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.76M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$4.97M |
| 4 |
Jennison Associates
New York
|
-$4.75M |
| 5 |
FAM
Fred Alger Management
New York
|
-$4.51M |
BLFS Hedge Fund Activity: Q3 2023 in Review
153 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2023, worth a combined $602M — down 33% from $897M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of BLFS and 22 opened new positions — a net loss of 3 holders — while 55 trimmed existing stakes and 52 added.
The largest buyer was Millennium Management, adding an estimated $28.5M. The largest seller was British Columbia Investment Management, exiting entirely with an estimated $8.84M sold.
- 153 institutional investors held BioLife Solutions (BLFS) as of Q3 2023, down from 156 in Q2 2023.
- Funds reported $602M of BioLife Solutions stock for Q3 2023, down 33% quarter-over-quarter.
- 22 funds opened new BioLife Solutions positions in Q3 2023 and 25 closed out, a net change of -3 holders.
- The largest BioLife Solutions buyer in Q3 2023 was Millennium Management, an estimated $28.5M added.
- The largest BioLife Solutions seller in Q3 2023 was British Columbia Investment Management, an estimated $8.84M sold.
Based on aggregated 13F filings for Q3 2023.